These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4195790)

  • 1. Side-effects of L-dopa in postencephalitic parkinsonism.
    Crawford JP
    Lancet; 1970 Sep; 2(7674):660. PubMed ID: 4195790
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa in postencephalitic parkinsonism.
    Calne DB; Stern GM; Laurence DR; Sharkey J; Armitage P
    Lancet; 1969 Apr; 1(7598):744-6. PubMed ID: 4180215
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined treatment of parkinsonism with L-dopa and amantadine.
    Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
    Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
    [No Abstract]   [Full Text] [Related]  

  • 4. L-dopa for postencephalitic Parkinsonism.
    Krasner N; Cornelius JM
    Br Med J; 1970 Nov; 4(5733):496. PubMed ID: 5481239
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment failures with L-dopa in Parkinsonism.
    Julsrud OJ
    Acta Neurol Scand Suppl; 1972; 51():123-4. PubMed ID: 4514337
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment of Parkinsonism with L-dopa.
    Presthus J; Holmsen R
    Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa in postencephalitic parkinsonism.
    Hunter KR; Stern GM; Sharkey J
    Lancet; 1970 Dec; 2(7687):1366-7. PubMed ID: 4098944
    [No Abstract]   [Full Text] [Related]  

  • 10. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of patients with postencephalitic Parkinsonism to levodopa.
    Duvoisin RC; Lobo-Antunes J; Yahr MD
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):487-95. PubMed ID: 5049808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal mouth-movements and oral damage associated with L-DOPA treatment.
    Sacks OW; Ross SJ; DePaola DP; Kohl MS
    Ann Dent; 1970; 29(4):130-44. PubMed ID: 5275661
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychic manifestations during treatment of Parkinson's disease with L-dopa].
    Bonduelle M
    Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897
    [No Abstract]   [Full Text] [Related]  

  • 14. Respiratory disturbance during L-dopa treatment of Parkinson's syndrome.
    Granerus AK; Jagenburg R; Nilsson NJ; Svanborg A
    Acta Med Scand; 1974; 195(1-2):39-43. PubMed ID: 4817091
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of L-dopa treatment and its principal side effects in aged subjects].
    Antonini F; Baroni A; Bucalossi A; Roveyaz L
    Gerontol Clin (Basel); 1972; 14(5):297-309. PubMed ID: 4144357
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effects of levodopa in the severely disabled patient.
    Sacks OW; Messeloff CR; Schwartz WF
    JAMA; 1970 Sep; 213(13):2270. PubMed ID: 5468938
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypersexual behavior complicating levodopa (I-dopa) therapy.
    Shapiro SK
    Minn Med; 1973 Jan; 56(1):58-9. PubMed ID: 4682591
    [No Abstract]   [Full Text] [Related]  

  • 20. DOPA in Parkinson's disease.
    Lancet; 1969 Apr; 1(7600):871-2. PubMed ID: 4180531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.